Accessibility Menu
Ion Beam Applications logo

Ion Beam Applications(OTC) IOBCF

Market Cap$542.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+255%
5 Year+0%
1 Year+42%
1 Month+1%
$18.51
+0.00%
+0.00Today
Ion Beam Applications last closing stock price
MetricPriceDate
Last closeUSD 18.512026-08-27
Ion Beam Applications stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.4%USD 18.582026-08-18
1 month+1.13%USD 18.302026-07-24
3 month+4.27%USD 17.752026-05-29
Year to date+23.16%USD 15.032025-12-31
1 year+41.81%USD 13.052025-08-25
3 year+43.7%USD 12.882023-08-28
5 year+0.34%USD 18.442021-08-26
Since inception+254.55%USD 5.222003-09-10

Ion Beam Applications Financials at a Glance

Market Cap

$542.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.23B

Net Income (TTM)

€41.49M

EPS (TTM)

$0.50

P/E Ratio

19.15

Dividend

$0.29

Beta (Volatility)

0.28 (Low)

Price

$18.51

Volume

8

Open

$19.50

Previous Close

$18.51

Daily Range

$18.51 - $19.50

52-Week Range

$11.45 - $20.10

Estimated Earnings Date

Mar 25, 2027

IOBCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ion Beam Applications

Ion Beam Applications S.A. (IBA) is a leading company in the medical devices sector, specializing in advanced equipment and software solutions for cancer treatment. With a strong presence in Belgium, the United States, and other international markets, IBA focuses on proton therapy and dosimetry, providing innovative solutions to enhance cancer care.

Products and Services
  • Proton therapy systems for cancer treatment
  • Cyclotron machines for radioisotope production
  • Dosimetry tools for radiation oncology precision
Growth Outlook
  • Recent quarterly revenue reached €315 million, indicating strong demand
  • Strategic partnerships enhance research capabilities and product offerings
  • Focus on expanding international markets supports long-term growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of €1.2 billion reflects solid performance
  • Net income for the latest quarter was €15.2 million, showcasing profitability
  • Current ratio of 0.99 indicates effective management of short-term liabilities
Ion Beam Applications S.A. has established itself as a key player in the medical devices industry, particularly in cancer treatment technologies. The company's commitment to innovation is evident through its advanced proton therapy systems and dosimetry tools, which are crucial for improving patient outcomes. Recent financial performance highlights a robust revenue stream and profitability, positioning IBA favorably for future growth. The strategic partnerships with research institutions further enhance its capabilities, ensuring that IBA remains at the forefront of medical technology advancements. With a focus on expanding its international footprint, the company is well-positioned to capitalize on the growing demand for cancer treatment solutions.
AI Generated • Aug 9, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

2,302

CEO

Olivier Legrain

Website

www.iba-worldwide.com

Headquarters

Louvain-la-Neuve, BU 1348, BE

IOBCF Financials

Key Financial Metrics (TTM)

Gross Margin

34.19%

Operating Margin

5.13%

Net Income Margin

3.84%

Return on Equity

19.93%

Return on Capital

9.10%

Return on Assets

3.26%

Earnings Yield

5.22%

Dividend Yield

1.57%

Payout Ratio

28.92%

Stock Overview

Market Cap

$542.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.33M

Volume

8

Avg. Volume

387.313

Financials (TTM)

Gross Profit

€404.43M

Operating Income

€65.98M

EBITDA

€93.28M

Operating Cash Flow

€6.00M

Capital Expenditure

-€13.69M

Free Cash Flow

-€7.69M

Cash & ST Invst.

€43.93M

Total Debt

€118.62M

Ion Beam Applications Performance Analysis

Ion Beam Applications annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 379,685,4912.6%
20232023-12-31EUR 504,520,97532.9%
20242024-12-31EUR 538,851,8226.8%
20252025-12-31EUR 699,915,83129.9%
Ion Beam Applications sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3141.3%
Q22025-06-304.5%
Q42025-12-313.4%
Q22026-06-302.6%
Ion Beam Applications annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.2138.8%
20232023-12-31EUR -0.34N/A
20242024-12-31EUR 0.34N/A
20252025-12-31EUR 0.4739.7%
Ion Beam Applications sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31288.6%
Q22025-06-30-113.2%
Q42025-12-31696.3%
Q22026-06-30-40.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€323.22M

+56.6%

Gross Profit

€108.74M

+55.7%

Gross Margin

33.64%

N/A

Market Cap

$542.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$235.79K

N/A

Employees

2,302

N/A

Net Income

€9.29M

+190.1%

EBITDA

€23.86M

+6515.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€43.93M

-27.3%

Total Debt

€118.62M

+97.8%

Accounts Receivable

€237.74M

+43.5%

Inventory

€166.95M

+10.2%

Long Term Debt

€81.78M

+181.3%

Short Term Debt

€36.84M

+19.2%

Return on Assets

3.26%

N/A

Return on Invested Capital

15.13%

N/A

Free Cash Flow

-€10.68M

+79.8%

Operating Cash Flow

-€8.29M

+83.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
COGZFCogstate Limited
$2.40+0.00%
PTCHFPureTech Health plc
$1.57+0.00%
DMTRF3-D Matrix, Ltd.
$2.50+0.00%
CLVLFClinuvel Pharmaceuticals Limited
$5.92-1.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$219.70-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.35-0.06%
INTCIntel
$88.98-0.01%
BITOProShares Trust - ProShares Bitcoin ETF
$10.44-0.02%

Questions About IOBCF

What is the current price of Ion Beam Applications?

Ion Beam Applications is trading at $18.51 per share.

What is the 52-week range for Ion Beam Applications?

Over the past 52 weeks, Ion Beam Applications has traded between $11.45 and $20.10.

How much debt does Ion Beam Applications have?

As of the most recent reporting period, Ion Beam Applications reported total debt of €137.28M.

How much cash does Ion Beam Applications have on hand?

Ion Beam Applications reported €75.97M in cash and cash equivalents in its most recent financial results.

What is Ion Beam Applications’s dividend yield?

Ion Beam Applications currently has a dividend yield of 1.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services